{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TVRD"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVRD\",,,,,undefined,":{"symbol":"TVRD","market":"US","secType":"STK","nameCN":"Tvardi Therapeutics Inc","latestPrice":24.61,"timestamp":1751054400000,"preClose":25.21,"halted":0,"volume":515466,"hourTrading":{"tag":"盘后","latestPrice":24.61,"preClose":24.61,"latestTime":"17:55 EDT","volume":154114,"amount":3792718.398296,"timestamp":1751061340345},"delay":0,"floatShares":7933194,"shares":9360904,"eps":-15.531682,"marketStatus":"Market Closed","change":-0.6,"latestTime":"06-27 16:00:00 EDT","open":24.82,"high":25.5921,"low":23.89,"amount":12680242.465086,"amplitude":0.067517,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-15.531682,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751270400000},"marketStatusCode":7,"adr":0,"listingDate":1391144400000,"exchange":"NASDAQ","adjPreClose":25.21,"preHourTrading":{"tag":"盘前","latestPrice":25.25,"preClose":25.21,"latestTime":"09:29 EDT","volume":15,"amount":378.75,"timestamp":1751030970083},"postHourTrading":{"tag":"盘后","latestPrice":24.61,"preClose":24.61,"latestTime":"17:55 EDT","volume":154114,"amount":3792718.398296,"timestamp":1751061340345},"volumeRatio":3.691154},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVRD\",,,,,undefined,":{"symbol":"TVRD","floatShares":7933194,"roa":"--","roe":"--","lyrEps":-15.531682,"volumeRatio":3.691154,"shares":9360904,"dividePrice":0,"high":25.5921,"amplitude":0.067517,"preClose":25.21,"low":23.89,"week52Low":8.1252,"pbRate":"--","week52High":34.31,"institutionHeld":0,"latestPrice":24.61,"eps":-15.531682,"divideRate":0,"volume":515466,"delay":0,"ttmEps":-15.531682,"open":24.82,"prevYearClose":18.36,"prevWeekClose":25.77,"prevMonthClose":28.34,"prevQuarterClose":15.21,"fiveDayClose":25.77,"twentyDayClose":29.86,"sixtyDayClose":14.82},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TVRD\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVRD\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543493895","title":"BUZZ-Tvardi Therapeutics up after Piper Sandler starts coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2543493895","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543493895?lang=en_us&edition=fundamental","pubTime":"2025-06-13 01:01","pubTimestamp":1749747711,"startTime":"0","endTime":"0","summary":"BUZZ-Tvardi Therapeutics up after Piper Sandler starts coverage** Shares of Tvardi Therapeutics TVRD.O rise 4.5% to $27.40** Piper Sandler initiates coverage of TVRD with an \"overweight\" rating and PT of $78 ** Piper believes that TVRD's lead drug, TTI-101, is positioned to drive broad improvement with an optimal profile** TTI-101 is uniquely positioned to drive meaningful anti-fibrotic effects for idiopathic pulmonary fibrosis , a chronic lung disease, at cellular and immune levels - brokerage** TVRD is developing TTI-109 as a next generation STAT3 inhibitor, with investigational new drug application submitted in June 2025 ** TTI-109 offers a significant pipeline opportunity for TVRD with an optimized product profile and extended coverage to ensure sustained use over time - Piper Sandler** TVRD stock up ~43% YTD, as of last close","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nL4N3SF164:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TVRD"],"gpt_icon":0},{"id":"2542359882","title":"Tvardi Therapeutics Inc : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $78","url":"https://stock-news.laohu8.com/highlight/detail?id=2542359882","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542359882?lang=en_us&edition=fundamental","pubTime":"2025-06-12 15:38","pubTimestamp":1749713919,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nFWN3SF060:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVRD","BK4007"],"gpt_icon":0},{"id":"2540115767","title":"Tvardi Therapeutics (TVRD) Receives a New Rating from BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2540115767","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540115767?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:16","pubTimestamp":1748862979,"startTime":"0","endTime":"0","summary":"Tvardi Therapeutics (TVRD – Research Report) received a Buy rating and a $55.00 price target from BTIG analyst Julian Harrison today. According to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/tvardi-therapeutics-tvrd-receives-a-new-rating-from-btig-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/tvardi-therapeutics-tvrd-receives-a-new-rating-from-btig-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVRD"],"gpt_icon":0},{"id":"2539427074","title":"Tvardi Therapeutics files to sell 2.08M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2539427074","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539427074?lang=en_us&edition=fundamental","pubTime":"2025-05-31 04:10","pubTimestamp":1748635825,"startTime":"0","endTime":"0","summary":"16:05 EDT Tvardi Therapeutics (TVRD) files to sell 2.08M shares of common stock for holders Published first on TheFly – the ultimate source for rea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tvardi-therapeutics-files-to-sell-2-08m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tvardi-therapeutics-files-to-sell-2-08m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVRD","BK4007","BK4539","BK4139","LENZ"],"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"TVRD","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-3.22},{"market":"US","date":"2025-04-16","symbol":"TVRD","defaultRemindTime":1744810200000,"type":"split","dateTimestamp":1744776000000,"forFactor":3,"toFactor":1,"ratio":3},{"market":"US","date":"2025-03-11","symbol":"TVRD","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-12-31","symbol":"TVRD","defaultRemindTime":1735655400000,"type":"split","dateTimestamp":1735621200000,"forFactor":12,"toFactor":1,"ratio":12},{"market":"US","date":"2024-11-14","symbol":"TVRD","fiscalQuarterEnding":"2024/09","expectedEps":-0.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVRD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVRD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1749787200000}}}